Results 11 to 20 of about 7,952,783 (243)

Ferritin Nanocages with Biologically Orthogonal Conjugation for Vascular Targeting and Imaging. [PDF]

Bioconjug Chem, 2018
Khoshnejad M, Greineder CF, Pulsipher KW, Villa CH, Altun B, Pan DC, Tsourkas A, Dmochowski IJ, Muzykantov VR.   +8 more
europepmc   +2 more sources

Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules. [PDF]

J Pathol, 2018
He B, Jabouille A, Steri V, Johansson-Percival A, Michael IP, Kotamraju VR, Junckerstorff R, Nowak AK, Hamzah J, Lee G, Bergers G, Ganss R.   +11 more
europepmc   +2 more sources

Vascular Targeting of a Gold Nanoparticle to Breast Cancer Metastasis. [PDF]

J Pharm Sci, 2015
Peiris PM, Deb P, Doolittle E, Doron G, Goldberg A, Govender P, Shah S, Rao S, Carbone S, Cotey T, Sylvestre M, Singh S, Schiemann WP, Lee Z, Karathanasis E.   +14 more
europepmc   +2 more sources

Vascular targeting of antithrombotic agents. [PDF]

IUBMB Life, 2011
AbstractIn this review we discuss the limited efficacy for current pharmacological agents used in prophylaxis and treatment of thrombosis and highlight targeted delivery of anti‐thrombotic agents to fibrin, platelets, red blood cells and endothelium.
Carnemolla R, Muzykantov VR.
europepmc   +4 more sources

Non-affinity factors modulating vascular targeting of nano- and microcarriers. [PDF]

Adv Drug Deliv Rev, 2016
Myerson JW, Anselmo AC, Liu Y, Mitragotri S, Eckmann DM, Muzykantov VR.   +5 more
europepmc   +2 more sources

Nanogold Functionalized With Lipoamide-isoDGR: A Simple, Robust and Versatile Nanosystem for αvβ3-Integrin Targeting

Frontiers in Chemistry, 2021
Gold nanoparticles functionalized with isoDGR, a tripeptide motif that recognizes αvβ3 integrin overexpressed in tumor vessels, have been used as nano-vectors for the delivery of cytokines to tumors.
Angelina Sacchi, Anna Maria Gasparri, Matteo Monieri, Giulia Anderluzzi, Barbara Colombo, Alessandro Gori, Angelo Corti, Angelo Corti, Flavio Curnis   +8 more
doaj   +1 more source

Neuropilin-1 and Integrins as Receptors for Chromogranin A-Derived Peptides

Pharmaceutics, 2022
Human chromogranin A (CgA), a 439 residue-long member of the “granin” secretory protein family, is the precursor of several peptides and polypeptides involved in the regulation of the innate immunity, cardiovascular system, metabolism, angiogenesis ...
Angelo Corti, Giulia Anderluzzi, Flavio Curnis   +2 more
doaj   +1 more source

Development of a Combined Lipid-Based Nanoparticle Formulation for Enhanced siRNA Delivery to Vascular Endothelial Cells

Pharmaceutics, 2022
Low transfection efficiency in endothelial cells (EC) is still a bottleneck for the majority of siRNA-based vascular delivery approaches. In this work, we developed a lipid-based nanoparticle (LNP) formulation based on a combination of a permanently ...
Yutong He, Dongdong Bi, Josée A. Plantinga, Grietje Molema, Jeroen Bussmann, Jan A. A. M. Kamps   +5 more
doaj   +1 more source

A simple and robust nanosystem for photoacoustic imaging of bladder cancer based on α5β1-targeted gold nanorods

Journal of Nanobiotechnology, 2023
Background Early detection and removal of bladder cancer in patients is crucial to prevent tumor recurrence and progression. Because current imaging techniques may fail to detect small lesions of in situ carcinomas, patients with bladder cancer often ...
Massimo Alfano, Elisa Alchera, Angelina Sacchi, Alessandro Gori, Giacomo Quilici, Irene Locatelli, Chiara Venegoni, Roberta Lucianò, Anna Maria Gasparri, Barbara Colombo, Giulia Taiè, Jithin Jose, Paolo Armanetti, Luca Menichetti, Giovanna Musco, Andrea Salonia, Angelo Corti, Flavio Curnis   +17 more
doaj   +1 more source

Liposomal Drug Delivery Systems for Cancer Therapy: The Rotterdam Experience

Pharmaceutics, 2022
At the Nanomedicine Innovation Center (NICE) at the Erasmus MC in Rotterdam, we have approached the treatment of cancer by starting with a vision of first establishing a platform that enables us to overcome the low levels of drugs delivered to tumors and
Mohamadreza Amin, Ann L. B. Seynhaeve, Majid Sharifi, Mojtaba Falahati, Timo L. M. ten Hagen   +4 more
doaj   +1 more source